BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 27
• 28
• 29

• BioCapital

  Health Diagnostic Laboratory Inc. Release: Dr. Michael Richman to Analyze the Relevance of MTHFR Polymorphisms in Venous Disease with or without Concomitant Thrombosis

  December 1, 2011

   · 

  3 min read
• Deals

  Laboratory Corporation of America Holdings (LabCorp) Extends Tender Offer for All Outstanding Shares of Orchid Cellmark

  December 1, 2011

   · 

  1 min read
• Business

  AVEO Pharmaceuticals, Inc. and Boehringer Ingelheim Corporation Announce Manufacturing Agreement for Ficlatuzumab

  December 1, 2011

   · 

  1 min read
• Pfizer Inc. Release: New Research Initiative Examines Economic Impact of Smoke-free Policies on Restaurants and Bars

  December 1, 2011

   · 

  4 min read
• Policy

  The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in Hospira, Inc. of Class Action Lawsuit and the Deadline of January 20, 2012 to Seek a Lead Plaintiff Position

  December 1, 2011

   · 

  2 min read
• BioMidwest

  Array BioPharma, Inc. to Host Analyst and Investor Day Featuring Distinguished Clinical Investigators

  December 1, 2011

   · 

  1 min read
• Drug Development

  Merrimack Pharmaceuticals Inc. Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors

  December 1, 2011

   · 

  1 min read
• Business

  Galleon Pharmaceuticals, Inc. Names Lynne Brookes Senior Vice President and Chief Business Officer

  December 1, 2011

   · 

  1 min read
• Biotech Bay

  Amarantus BioSciences, Inc. to Present at the National Investment Banking Association’s (NIBA) 120th Investment Conference

  December 1, 2011

   · 

  1 min read
• Business

  MacroGenics, Inc. Inks Pharma Deal With Servier Worth Up to $450 Million

  December 1, 2011

   · 

  6 min read